Document Detail


Breakthrough in treating gestational diabetes mellitus.
MedLine Citation:
PMID:  15317230     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
QUESTION: I practise in a remote community in Manitoba. Quite a few of my patients experience gestational diabetes. Their compliance with the insulin regimen is abysmal. Can I give them an oral medication?
ANSWER: Recent studies have indicated that glyburide does not cross the human placenta and that its effectiveness and safety profiles are similar to those of insulin.
Authors:
Gideon Koren
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian family physician Médecin de famille canadien     Volume:  50     ISSN:  0008-350X     ISO Abbreviation:  Can Fam Physician     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2004-08-19     Completed Date:  2004-09-14     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  0120300     Medline TA:  Can Fam Physician     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  987, 989     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Diabetes, Gestational / drug therapy*
Female
Glyburide / administration & dosage,  pharmacokinetics,  therapeutic use*
Humans
Hypoglycemic Agents / administration & dosage,  pharmacokinetics,  therapeutic use*
Insulin / therapeutic use
Manitoba
Patient Compliance
Pregnancy
Rural Health Services
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 0/Insulin; 10238-21-8/Glyburide
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular genetic analysis of TPO and CD4 loci among two endogamous ethnic groups of Maharashtra in ...
Next Document:  Bone health. New role for vitamin K?